Back to Depression And Anxiety
This trial is complete. It is no longer accepting participants.

NCT00247429

NCT00247429
Completed Not Applicable

Who may be able to join

Who might be able to join this trial:

  • You are older than 60 years of age
  • You are experiencing symptoms of depression along with anxiety, measured as moderate or severe on a standard depression rating scale (confirm with trial site)

Who may not be able to join:

  • You have taken part in another clinical study within the 3 months before this trial starts
  • You have a known allergy or sensitivity to the medication venlafaxine
  • You have certain significant health abnormalities that would make taking venlafaxine unsuitable for you, based on the medication's official guidelines (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

Trial details

Status
Completed
Phase
Not Applicable
Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer
Registry
clinicaltrials_gov
Start date
1 July 2004
Est. completion
1 October 2005

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

View original record on ClinicalTrials.gov